Total Mesorectal Excision(TME) With Lateral Lymph Node Dissection Versus TME After Neoadjuvant Chemo-radiotherapy
Recruiting now · Not applicable
Conditions studied: Rectal Neoplasm Malignant
In brief
Treatment for Low rectal cancer, especially in patients with regional lymph node metastasis are quite different between Japanese guideline (JSCCR) and western countries' guideline (NCCN, ESMO). While Japanese scholars advocate total mesorectal excision (TME) plus lateral lymph node dissection (LLND), European and American scholars advocate TME alone after Neoadjuvant Chemo-radiotherapy (nCRT), without the need of LLND. Accordingly, this clinical trial is designed to directly compare the efficacy and safety of these two treatment strategies for low rectal cancer with regional lymph node metastasis. It will provide high-level clinical evidence for the treatment of low rectal cancer with suspected local lymph node metastasis
Key facts
- Study ID
- NCT03587480
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
- People needed
- 250
- Starts
- 2018-12-17
- Expected to finish
- 2030-05-24
- Last updated by the study team
- 2022-11-25
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Histologically confirmed adenocarcinoma(below the peritoneal reflection) Clinical stage Ⅲ
- Tumor is capable of performing radical recession
- No past history of chemotherapy, pelvic radiation of other cancers.
- Written informed consent
- Lower tumor margin is confirmed below the peritoneal reflection
- Clinical state T(1-3)N(1-2)M0 is confirmed by the multiple disciplines team(MDT) including surgeons,diagnostic radiologist,radiation oncologist and medical oncologists base on MRI and endorectal ultrasound -
You may not qualify if…
- Past history of other cancers
- Multiple Primary Colorectal Cancers or Familial adenomatous polyposis(FAP)
- Combine with inflammatory bowl disease(IBD)
- Recurrence tumor or invade other organs
- Combine with obstruction,perforation or bleeding which need emergency surgery.
- Local tumor invade the external sphincter, levator ani muscle or adjacent organs
- Participant join other clinical trials in 4 weeks.
- American Society of Anesthesiologists(ASA) ≥Ⅳ and/or Eastern Cooperative Oncology Group(ECOG) ≤2
- Pregnant or lactating patients
- Severity infection before operation
- Psychological disorder
- Severe dysfunction of organs or other contraindications
- Cardiac infarction within six months
- Severe pulmonary emphysema and pulmonary fibrosis
- Doctor's decision for exclusion
- Operative findings:
- Tumor invade other organs Lower tumor margin is above the peritoneal reflection
Where it is running
- The Sixth Affiliate Hospital of Sun Yat-Sen University — Guangzhou, Guangdong, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.